tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dianthus reports Q3 EPS (97c), consensus (90c)
PremiumThe FlyDianthus reports Q3 EPS (97c), consensus (90c)
20d ago
Dianthus Therapeutics Reports Positive Phase 2 Results
Premium
Company Announcements
Dianthus Therapeutics Reports Positive Phase 2 Results
22d ago
Promising Clinical Data and Strategic Plans Position Dianthus Therapeutics as an Attractive Investment Opportunity
Premium
Ratings
Promising Clinical Data and Strategic Plans Position Dianthus Therapeutics as an Attractive Investment Opportunity
26d ago
Dianthus Therapeutics Signs License Agreement with Nanjing Leads
PremiumCompany AnnouncementsDianthus Therapeutics Signs License Agreement with Nanjing Leads
1M ago
Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212
Premium
The Fly
Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212
1M ago
3 Best Stocks to Buy Now, 10/14/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 10/14/2025, According to Top Analysts
1M ago
Dianthus price target raised to $65 from $52 at Stifel
PremiumThe FlyDianthus price target raised to $65 from $52 at Stifel
2M ago
Dianthus price target raised to $44 from $42 at Wedbush
Premium
The Fly
Dianthus price target raised to $44 from $42 at Wedbush
2M ago
Dianthus Therapeutics Raises $270M Through Stock Offering
Premium
Company Announcements
Dianthus Therapeutics Raises $270M Through Stock Offering
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100